Regional Account Manager- Neurology (Houston Based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Cytokinetics
Cardiovascular Account Specialist - U.S. Sales, Dallas East, TX
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Medical DevicesIndustries
Requirements
Candidates are required to possess a Bachelor’s degree and a minimum of 5 years of experience in biotech or pharmaceutical sales, with preference given to territory ownership experience and prior experience in cardiology, rare diseases, or specialty products. Experience with specialty product launches is also preferred.
Responsibilities
As a Cardiovascular Account Specialist, you will introduce Cytokinetics in your territory and launch its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM), by developing territory-specific account plans, identifying and developing strategic IDNs and Hospitals, cardiology clinics, and specialty pharmacies, and serving as a subject matter expert and resource to customers while coordinating with a local integrated field team to deliver clinically relevant information and support patient needs.
Skills
Biotech
Pharma Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Customer Relationship Management
Healthcare Communication
Strategic Thinking
Cytokinetics
Develops drugs for muscle function disorders
About Cytokinetics
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Key Metrics
South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees